Skip To Main Content
Yingwei Tan on Muck Rack

Yingwei Tan

As seen in: Frontiers
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Yingwei

Contact Yingwei, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Celecoxib in oncology: targeting the COX-2/PGE2 axis to reprogram the tumor immune microenvironment and enhance multimodal therapy

|
By Kuan Yang, Xiaoting Zhong, Yi Zhou, Jianming Ye, Boyang Kuang, Yingwei Tan
| Frontiers
1 Introduction Malignant neoplasms are a major global public health challenge, with nearly 20 million new cancer cases as well as 9.7 million cancer deaths in 2022 according to global cancer statistics (Bray et al., 2024), and a complex challenge for clinical oncology, characterized by heterogeneity and the ability to evade immune surveillance.
Open in Who Shared Issue with article?
See all 1 articles